Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Zealand Pharma to participate in the Jefferies Global Healthcare Conference
Zealand Pharma to participate in the Jefferies Global Healthcare Conference
GlobeNewswire

Press release – No. 11 / 2026 Zealand Pharma to participate in the Jefferies Global Healthcare Conference Copenhagen, Denmark, May 27, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the…

globenewswire.com - Zealand Pharma - Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions
Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions
GlobeNewswire

Press release – No. 10 / 2026 Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions Late-breaking Phase 2 ZUPREME-1 data on petrelintide to be featured as ePoster Theater presentation and poster…

fortune.com - John Kell - Sanofi is building its own AI ecosystem to give the French pharma giant an edge
Sanofi is building its own AI ecosystem to give the French pharma giant an edge
Fortune

In the early days of the generative artificial intelligence boom, Sanofi's chief digital officer, Emmanuel Frenehard, wasn't particularly impressed with the AI tools that were being pitched. The French pharmaceutical giant eschewed licensing an…

thehindu.com - N. Ravi Kumar - Indian pharma set to gain from CEPA with Oman
Indian pharma set to gain from CEPA with Oman
The Hindu

Ahead of the India–Oman Comprehensive Economic Partnership Agreement implementation, pharma exporters body Pharmexcil has highlighted the opportunities that await Indian pharmaceutical, AYUSH and wellness sectors. “One of the…

fool.com - Sara Appino - PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem
PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem
The Motley Fool

The VanEck Pharmaceutical ETF (PPH 0.83%) provides targeted exposure to drug manufacturers, while the iShares Global Healthcare ETF (IXJ 0.86%) offers a broader reach across the international medical industry including biotechnology and equipment.

newswire.ca - Innocan Pharma Posts Strong Q1 2026 Results*, With Revenue Surging 29.7% to US$6.47M
Innocan Pharma Posts Strong Q1 2026 Results*, With Revenue Surging 29.7% to US$6.47M
CNW

HERZLIYA, Israel and CALGARY, AB, May 27, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the 'Company' or 'Innocan'), a pharmaceutical technology company focusing on developing innovative drug delivery platform…

republicworld.com - Initiative Desk - Bollywood Actor Salim Diwan Takes Over Krux Pharma Pvt. Ltd. in 50 Million USD Deal for Strategic Global Business Expansion
Bollywood Actor Salim Diwan Takes Over Krux Pharma Pvt. Ltd. in 50 Million USD Deal for Strategic Global Business Expansion
Republic World

Bollywood actor and entrepreneur Salim Diwan has once again made headlines—this time not for a film, but for a significant business milestone. Diwan has acquired pharmaceutical company Krux Pharma Pvt. Ltd. in a deal valued at 50 million…

marketbeat.com - HighTower Advisors LLC Lowers Holdings in BridgeBio Pharma, Inc. $BBIO
HighTower Advisors LLC Lowers Holdings in BridgeBio Pharma, Inc. $BBIO
MarketBeat

HighTower Advisors LLC cut its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 60.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor…

psychologytoday.com - David M. Carreon,  MD - Have Hope: Psychiatry Officially Embraces the Future
Have Hope: Psychiatry Officially Embraces the Future
Psychology Today

In a hallowed tradition, psychiatrists from across the country gathered together to meet and discuss our field as we have done most years since 1844. What was different this year at the American Psychiatric Association meeting was that the…

businessinsider.com - Lara O'Reilly - How to fix AI's branding problem, according to top marketers
How to fix AI's branding problem, according to top marketers
Business Insider

How do you solve a branding problem like AI? Marketers have some ideas, like borrowing from P&G's marketing playbook or creating a think tank. It's no secret that AI is getting a bad rap. Boos at college graduation speeches. AI-related layoffs.

adweek.com - Robert Klara - Marketers Keep Conflating Gen X With Boomers-And It's Costing Them
Marketers Keep Conflating Gen X With Boomers-And It's Costing Them
ADWEEK

The future of brands gets decided here. Join the industry's top marketers at Brandweek for the ideas, insights, and connections shaping what's next. Get your ticket. Gen X is known as “the forgotten generation,” and that appears to…

forbes.com - Mayank Kejriwal - The Next AI Opportunity Is The Research Office
The Next AI Opportunity Is The Research Office
Forbes

Mayank Kejriwal - CEO and Co-Founder of GRAIL. ​When business leaders talk about AI, the conversation usually starts with customer service, software development or marketing. I believe one of the biggest overlooked opportunities is the…

scmp.com - Julie Zhang - China's biotech boom drives surge in home-grown innovative drug approvals
China's biotech boom drives surge in home-grown innovative drug approvals
South China Morning Post

Home-grown innovative drugs make up most of the medicines China's drug regulator has approved for sale so far this year, underscoring the country's biotech boom. Of the 19 innovative drugs cleared by the National Medical Products Administration…

seekingalpha.com - Dulan Lokuwithana - BridgeBio gains FDA review for muscle disorder drug (BBIO)
BridgeBio gains FDA review for muscle disorder drug (BBIO)
Seeking Alpha

Shares of BridgeBio Pharma () traded higher on Wednesday after the FDA granted priority review for its marketing application for BBP-418, an oral therapy targeting a rare muscle disorder called limb-girdle muscular dystrophy. The regulator has…

forbes.com - Brett Owens - This Boring Income Portfolio Strategy Could Unlock 300%+ Upside
This Boring Income Portfolio Strategy Could Unlock 300%+ Upside
Forbes

Growth business bar graph on analyzed data. Most people think you can't time the market. That's nonsense. Not only is it possible, it's easy. Today I'm going to show you how to do it with far less risk than the average investor would face. The best…

Receive a Daily briefing on Pharma Industry News

Get Started